Product Information
Registration Status: InactiveTHIS PRODUCT HAS BEEN DEREGISTERED!
CARDIUM 30 TABLET 30mg is approved to be sold in Singapore with effective from 1996-02-13. It is marketed by DRUG HOUSES OF AUSTRALIA PTE LTD, with the registration number of SIN08574P.
This product contains Diltiazem 30mg in the form of TABLET, FILM-COATED. It is approved for ORAL use.
This product is manufactured by DRUG HOUSES OF AUSTRALIA PTE LTD in SINGAPORE.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Description
A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions. It is also teratogenic.
Indication
For the treatment of Hypertension
Mechanism of Action
Possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, diltiazem, like verapamil, inhibits the influx of extracellular calcium across both the myocardial and vascular smooth muscle cell membranes. The resultant inhibition of the contractile processes of the myocardial smooth muscle cells leads to dilation of the coronary and systemic arteries and improved oxygen delivery to the myocardial tissue.
Pharmacokinetics
- Absorption
- Diltiazem is well absorbed from the gastrointestinal tract but undergoes substantial hepatic first-pass effect.
- Distribution
- Metabolism
- Diltiazem is metabolized by and acts as an inhibitor of the CYP3A4 enzyme.
- Elimination
Toxicity
LD50=740mg/kg (orally in mice)
Active Ingredient/Synonyms
(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester | (2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one | (2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate | Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester | D-cis-diltiazem | Diltiazem | Diltiazemum | Diltiazem |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.